Dose-escalation strategy in refractory metastatic colorectal cancer: A change in terms of cost-effectiveness.

Jacopo Giuliani,Francesco Fiorica,Giovanni Ponturo,Maurizio Azzurro,Andrea Ruzzenente,Andrea Bonetti

Dose-escalation strategy in refractory metastatic colorectal cancer: A change in terms of cost-effectiveness.

2021

Jacopo Giuliani
Francesco Fiorica
Giovanni Ponturo
Maurizio Azzurro
Andrea Ruzzenente
Andrea Bonetti

The analysis was conducted to assess the pharmacological costs of regorafenib and trifluridine/tipiracil in the treatment of refractory metastatic colorectal cancer (mCRC). Pivotal phase III random...

Keywords:

dose escalation
Regorafenib
Trifluridine
Internal medicine
Medicine
Tipiracil
Colorectal cancer
Oncology
Refractory
cost effectiveness

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations